|
Post by kc on Jan 17, 2018 21:04:48 GMT -5
Doesn't matter. It is not necessary to define. Let us wait for 9 months to see what will happen. Go ahead to bet on the bankruptcy at that time. If it goes to bankruptcy, I fail with loosing $200K. If not, it is $50Billion business in 3~5 years. Ok, I already lost 200K. Not betting on bankruptcy but to say the "fundamental of the company is solid" is a bit of stretch isn't it? It should be a $50B dollar business I agree.........but it hasn't really gotten started now has it? Many of us have lost big bucks and I know that we all know who we are. Could the company still go bankrupt? Yes of course it can. Will it? I sure hope not as many of us have double or tripled down on our original loses. But Hey its only money. Will MannKind ever be a 50 Billion business. I don’t ever see that happening. Maybe a 5 to 10 billion company in 5 to 10 years. 50 is a big stretch.
|
|
|
Post by golfeveryday on Jan 17, 2018 21:12:31 GMT -5
Ok, I already lost 200K. Not betting on bankruptcy but to say the "fundamental of the company is solid" is a bit of stretch isn't it? It should be a $50B dollar business I agree.........but it hasn't really gotten started now has it? Many of us have lost big bucks and I know that we all know who we are. Could the company still go bankrupt? Yes of course it can. Will it? I sure hope not as many of us have double or tripled down on our original loses. But Hey its only money. Will MannKind ever be a 50 Billion business. I don’t ever see that happening. Maybe a 5 to 10 billion company in 5 to 10 years. 50 is a big stretch. 5B is very achievable and in muchless time I would say than your 5-10 year time frame.
|
|
|
Post by mannmade on Jan 17, 2018 21:36:53 GMT -5
As I recall Mnkd was once valued between $3B and $4B not that long ago, although it now seems like ages ago... I would be very happy with a 3B valuation within the next 12 to 18 months. With our current valuation at $298m as of the close today that would represent a 10 fold increase in pps share closed at $2.51 today or $25.10 at a $3B valuation. I would expect most of us would be very happy with that... GLTAL's!!!
|
|
|
Post by akemp3000 on Jan 17, 2018 22:23:44 GMT -5
All it would take for Mannkind to return to a $3B evaluation is the jump in scripts that many are expecting following the recent marketing push. This would relegate the Sanofi marketing saga to the dust bin and validate Afrezza back to the point in time where it was once valued at $3B. This would cause shorts to exit, institutional investors to come on board and the pps to climb. If new international partnerships and new TS pipeline partnerships are then added, the $3B would become the new floor...IMHO...GLTA!
|
|
|
Post by tz on Jan 17, 2018 22:43:13 GMT -5
In 2016, Sanofi's Lantus insulin sales is 3.9Billion in USA. This makes it 100B business. That is also the reason why Sanofi tried to shut off Afrezza when it was still a baby because Afrezza is a game changer and not its baby. It can only account maximum half of the total sales of Afrezza as its revenue i.e., 2B. Its market cap will drop significantly even if they can market Afrezza to 6B (impossible). Since Afrezza can squeeze Lantus' revenue, do you think they want to market Afrezza? If I were Sanofi, I definitely tried what I can do to kill it before it grows up.
|
|
|
Post by barnstormer on Jan 18, 2018 0:17:00 GMT -5
Well put and my feelings exactly. As much as we all respect Al Mann the SNY agreement didn't spell out specific resources that would be applied for marketing Afrezza. It isn't Mannkind's fault that Sanofi changed CEOs to one that had a bad taste in his mouth in regards to inhaled insulin. However, when you have a "blockbuster" their words not mine you must be protected from contingencies out of your control. Corporate lawyers make a lot of money drawing up contracts to protect a company's IP and future financial interests from the very thing that happened to Mannkind. The Mannkind, Sanofi agreement could have been drawn up on a bar napkin for what it was worth. Sanofi didn't do a single DTC campaign and there was no TV ads. Toujeo got all of the exposure and it has turned out to be an 'also ran' caliber insulin. Brandicourt will probably be fired from Sanofi for a string of poor performing drug programs like the flu vaccine that has less than 10% efficacy. Going forward if Mike has a partner I hope he hires some outside council to work out a better contract than Mannkind has done in the past.
|
|
|
Post by mytakeonit on Jan 18, 2018 0:27:10 GMT -5
Wow ... on this page alone ... I see MNKD valuation going from $298M ... to $3B - $4B ... to $5B ... to $50B ... and now $100B !!!
Glad that we all are thinking the same way and direction. GO MNKD !!!
|
|
|
Post by tz on Jan 18, 2018 1:30:15 GMT -5
With Afrezza alone, the sales will easily march to ~2B (novolog sales 1.6B in 2016). It is 20B market cap with that sales. Let alone the Technosphere platform. In October, some investor paid $6 a share to buy 10 million shares. If they buy 10M shares in the open market, do you think they can buy it at $6/share? The bear is walking away. Disappointed. It is the last dance of the shorts. To me, Mike seems driving the right direction. Is he a Pharmacy sales guy? When the sales reach 1m a week. The shorts die. The sales growth will be exponentially.
|
|
|
Post by kc on Jan 18, 2018 8:40:24 GMT -5
Sorry to tell you that the short never dies. The short never goes away. It does not matter if it’s this company or any other company. there are people out there who are going to short the stock. That is what they do.
|
|
|
Post by agedhippie on Jan 18, 2018 8:45:30 GMT -5
With Afrezza alone, the sales will easily march to ~2B (novolog sales 1.6B in 2016). It is 20B market cap with that sales. Let alone the Technosphere platform. In October, some investor paid $6 a share to buy 10 million shares. If they buy 10M shares in the open market, do you think they can buy it at $6/share? The bear is walking away. Disappointed. It is the last dance of the shorts. To me, Mike seems driving the right direction. Is he a Pharmacy sales guy? When the sales reach 1m a week. The shorts die. The sales growth will be exponentially. $2Bn ? Over what time scale? Could you buy 10M shares on the open market? Absolutely Mannkind has an average volume traded of almost 4M per day. Spread the buy over a couple of weeks and you could get 10M shares without moving the market at all.
|
|
|
Post by veritasfiliatemporis on Jan 18, 2018 9:07:25 GMT -5
I do not agree.. if you buy 10M shs open market price will skyrocket well above 6$ you can sell and buy 1sh 100 times a day
|
|
|
Post by traderdennis on Jan 18, 2018 9:22:42 GMT -5
With Afrezza alone, the sales will easily march to ~2B (novolog sales 1.6B in 2016). It is 20B market cap with that sales. Let alone the Technosphere platform. In October, some investor paid $6 a share to buy 10 million shares. If they buy 10M shares in the open market, do you think they can buy it at $6/share? The bear is walking away. Disappointed. It is the last dance of the shorts. To me, Mike seems driving the right direction. Is he a Pharmacy sales guy? When the sales reach 1m a week. The shorts die. The sales growth will be exponentially. Tz that investor who bought 10 million shares at six was Deerfield and others covering a short to make a small profit by selling closer to 6.70. Retail owns that ten million. This is the kind of post I believe is pumping the stock for an alterier motive.
|
|
|
Post by veritasfiliatemporis on Jan 18, 2018 11:19:52 GMT -5
I do not believe you can buy 10M shs at 6 and sell 10M at 6.70 and SP remains in a 6-6.7$ range, pls explain
|
|
|
Post by kc on Jan 18, 2018 11:27:08 GMT -5
One buyer could not have bought 10 million shares without disclosure. The offering had to of been purchased by multiple parties or we would’ve seen a filing with the SEC
5% or more requires SEC filing
|
|
|
Post by traderdennis on Jan 18, 2018 11:33:01 GMT -5
I do not believe you can buy 10M shs at 6 and sell 10M at 6.70 and SP remains in a 6-6.7$ range, pls explain Between October 5th and October 11th, sell 10 Million shares between 6.00 and 6.90 to open up a short position. On oct 5, 10, & 11th over 150 million shares are traded on those days. Then you are the investor who takes the 10 million shares in the direct placement to cover your brand new short. Not only do you make a small profit on the short, now the company has 57 Million dollars to pay more of your debt off.
|
|